BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27413552)

  • 1. Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients.
    Hosny MM; Sabek NA; El-Abaseri TB; Hassan FM; Farrag SH
    Int J Breast Cancer; 2016; 2016():9545241. PubMed ID: 27413552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue.
    Bhavani V; Srinivasulu M; Ahuja YR; Hasan Q
    Cancer Biomark; 2009; 5(4):207-13. PubMed ID: 19729830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation and expression changes of
    Li Q; Wei W; Jiang YI; Yang H; Liu J
    Oncol Lett; 2015 Apr; 9(4):1807-1813. PubMed ID: 25789047
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
    Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
    Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
    Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
    Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
    J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated
    Al-Showimi M; Al-Yousef N; Alharbi W; Alkhezayem S; Almalik O; Alhusaini H; Alghamdi A; Al-Moghrabi N
    Oncol Lett; 2022 Aug; 24(2):276. PubMed ID: 35782895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population.
    Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP
    Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
    Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
    Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.
    Ben Gacem R; Hachana M; Ziadi S; Amara K; Ksia F; Mokni M; Trimeche M
    Cancer Epidemiol; 2012 Apr; 36(2):190-7. PubMed ID: 21978880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
    Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
    Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles.
    Matros E; Wang ZC; Lodeiro G; Miron A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2005 May; 91(2):179-86. PubMed ID: 15868446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
    Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach.
    Oubaddou Y; Oukabli M; Fenniche S; Elktaibi A; Elochi MR; Al Bouzidi A; Qmichou Z; Dakka N; Diorio C; Richter A; Bakri Y; Ameziane El Hassani R
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.